Heavy ion carcinogenesis and human space exploration

Nature Reviews Cancer

Volumn 8, Issue 6, 2008, Pages 465-472

  Durante, Marco ^a,b   Cucinotta, Francis A ^c  

^a GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NASA JOHNSON SPACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; HEAVY ION;

CANCER RISK; CARCINOGENESIS; CHROMOSOME ABERRATION; COSMONAUT; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DNA DAMAGE; ENERGY; HEAVY ION RADIATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; RADIATION EXPOSURE; RETINOBLASTOMA; REVIEW; SPACE;

ASTRONAUTS; CHROMOSOME ABERRATIONS; COSMIC RADIATION; DISEASE SUSCEPTIBILITY; DNA DAMAGE; DNA REPAIR; HEAVY IONS; HUMANS; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; RISK FACTORS; SPACE FLIGHT;

EID: 44349143334     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2391     Document Type: Review

References (118)

1. Cucinotta, F. A. & Durante, M. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. Lancet Oncol. 7, 431-435 (2006).
2. National Council on Radiation Protection and Measurements. Information needed to make radiation protection recommendations for space missions beyond low-earth orbit. NCRP Report No. 153 (National Council on Radiation Protection and Measurements, Bethesda, 2006).
3. European Space Agency: HUMEX Study in the survivability and adaptation of humans to long-duration exploratory missions. ESA-ESTEC SP-1264, (Nordwijk, the Netherlands, 2003).
4. White, R. J. & Averner, M. Humans in space. Nature 409, 1115-1118 (2001).
5. Longnecker, D. & Molins, R. (eds). A Risk Reduction Strategy For Human Exploration Of Space: A Review of NASA's Bioastronautics Roadmap. (National Academies, Washington DC 2005).
6. National Council on Radiation Protection and Measurements: Acceptability of Risk from Radiation: Application to Human Space Flight. NCRP Symp. Proc. No. 3 (National Council on Radiaton, Bethesda, 1997).
7. Preston, D. L. et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997 Radiat. Res. 160, 381-407 (2003).
8. Cucinotta, F. A. et al. Space radiation cancer risks and uncertainties for Mars missions. Radiat. Res. 156, 682-688 (2001).
9. Cucinotta, F. A., Kim, M. H. & Ren, L. Evaluating shielding effectiveness for reducing space radiation cancer risks. Radiat. Meas. 41, 1173-1185 (2006).
10. Krämer, M. & Kraft, G. Calculations of heavy ion track structure. Radiat. Environ. Biophys. 33, 91-109 (1994).
11. Cucinotta, F. A., Nikjoo, H. & Goodhead, D. T. Model of the radial distribution of energy imparted in nanometer volumes from HZE particles. Radiat. Res. 153, 459-468 (2000).
12. Goodhead, D. T. Initial events in the cellular effects of ionising radiation: clustered damage in DNA. Int. J. Radiat. Biol. 65, 7-17 (1994).
13. Ponomarev, A. & Cucinotta, F. A. Chromatin loops are responsible for higher counts of small DNA fragments induced by high-LET radiation, while chromosomal domains do not affect the fragment sizes. Int. J. Radiat. Biol. 82, 293-305 (2006).
14. Prise, K. M. et al. A review of dsb induction data for varying quality radiations. Int. J. Radiat. Biol. 74, 173-184 (1998).
15. Sutherland, B. M., Bennett, P. V., Sidorkina, O. & Laval, J. Clustered DNA damages induced in isolated DNA and in human cells by low doses of ionizing radiation. Proc. Natl Acad. Sci. USA 97, 103-108 (2000).
16. Rydberg, B. et al. Dose-dependent misrejoining of radiation-induced DNA double-strand breaks in human fibroblasts: experimental and theoretical study for high- and low-LET radiation. Radiat. Res. 163, 526-534 (2005).
17. Leatherbarrow, E. L. et al. Induction and quantification of ?-H2AX foci following low and high LETirradiation. Int. J. Radiat. Biol. 82, 111-118 (2006).
18. Fakir, H. et al. Clusters of DNA double-strand breaks induced by different doses of nitrogen ions for various LETs: experimental measurements and theoretical analyses. Radiat. Res. 166, 917-927 (2006).
19. Hada, M. & Sutherland, B. M. Spectrum of complex DNA damages depends on the incident radiation. Radiat. Res. 165, 223-230 (2006).
20. Phillips, E. R. & McKinnnon, P. J. DNA doublestrand break repair and development. Oncogene 26, 7799-7808 (2007).
21. Löbrich, M. & Jeggo, P. A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nature Rev. Cancer 7, 861-869 (2007).
22. Wyman, C. & Kanaar, R. DNA double-strand break repair: all's well that ends well. Annu. Rev. Genet. 40, 363-383 (2006).
23. O'Driscoll, M. & Jeggo, P. A. The role of double-strand break repair - insights from human genetics. Nature Rev. Genet. 7, 45-54 (2006).
24. Costes, S. V. et al. Imaging features that discriminate between foci induced by high- and low-LET radiation in human fibroblasts. Radiat. Res. 165, 505-515 (2006).
25. Desai, N. et al. Immunofluorescent detection of DNA double strand breaks induced by high-LET radiation. Radiat. Res. 164, 518-521 (2005).
26. Riballo, E. et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis and proteins locating to γ-H2AX foci. Mol. Cell 16, 715-724 (2004).
27. Wang, J. et al. Artemis phosphorylation and function in response to damage. DNA Repair 4, 556-570 (2005).
28. Pluth, J. M. et al. DNA double strand break repair and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells. DNA Repair 7, 108-118 (2008).
29. Falck, J, Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR, and DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005).
30. Mari, P. O. et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl Acad. Sci. USA 103, 18597-18602 (2006).
31. Williams, E. S. et al. DNA double-strand breaks are not sufficient to initiate recruitment of TRF2. Nature Genet. 39, 696-698 (2007).
32. Uematsu, N. et al. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J. Cell Biol. 217, 219-229 (2007).
33. Jakob, B. et al. Live cell imaging of heavy-ion-induced radiation responses by beamline microscopy. Radiat. Res. 163, 681-90 (2005).
34. Costes, S. V. et al. Image-based modeling reveals dynamic redistribution of DNA damage into nuclear sub-domains. PLOS Comp. Biol. 3, 1477-1488 (2007).
35. Ding, L. et al. Gene expression changes in normal human skin fibroblasts induced by HZE-particle irradiation. Radiat. Res. 164, 523-526 (2005).
36. Kruhlak, M. J., Celeste, A. & Nussenzweig, A. Spatiotemporal dynamics of chromatin containing DNA breaks. Cell Cycle 5, 1910-1912 (2006).
37. Soutoglou, E. et al. Positional stability of single double-strand breaks in mammalian cells. Nature Cell Biol. 9, 675-682 (2007).
38. Cornforth, M. N. Perspectives on the formation of radiation-induced exchange aberrations. DNA Repair 5, 1182-1191 (2006).
39. George, K. et al. Biological effectiveness of accelerated particles for the induction of chromosome damage measured in metaphase and interphase human lymphocytes. Radiat. Res. 160, 425-435 (2003).
40. Tucker, J. D., Marples, B., Ramsey, M. J. & Lutze-Mann, L. H. Persistence of chromosome aberrations in mice acutely exposed to 56Fe+26 ions. Radiat. Res. 161, 648-655 (2004).
41. Rithidech, K.N., Honikel, L. & Whorton, E. B. mFISH analysis of chromosomal damage in bone marrow cells collected from CBA/CaJ mice following whole body exposure to 56Fe ions. Radiat. Environ. Biophys. 46, 137-45 (2007).
42. Durante, M., George, K., Wu, H. & Cucinotta, F. A. Karyotypes of human lymphocytes exposed to high-energy iron ions. Radiat. Res. 158, 581-590 (2002).
43. Johannes, C. et al. Chromosome intrachanges and interchanges detected by multicolor banding in lymphocytes: searching for clastogen signatures in the human genome. Radiat. Res. 161, 540-548 (2004).
44. Hada, M., Cucinotta, F. A., Gonda, S. R. & Wu, H. mBAND analysis of chromosomal aberrations in human epithelial cells exposed to low- and high-LET radiation. Radiat. Res. 168, 98-105 (2007).
45. Durante, M., George, K. & Cucinotta, F. A. Chromosomes lacking telomeres are present in the progeny of human lymphocytes exposed to heavy ions. Radiat. Res. 165, 51-58 (2006).
46. Durante, M., Biomarkers of space radiation risk. Radiat. Res. 164, 467-473 (2005).
47. Norppa, H. et al. Chromosomal aberrations an SCE as biomarkers of cancer risk. Mutat. Res. 600, 37-45 (2006).
48. Boffetta, P. et al. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am. J. Epidemiol. 165, 36-43 (2007).
49. International Atomic Energy Agency. Cytogenetic analysis for radiation dose assessment. IAEA Technical report no. 405. (IAEA, Vienna, 2001).
50. George, K. et al. Chromosome aberrations in the blood lymphocytes of astronauts after space flight. Radiat. Res. 156, 731-738 (2001).
51. George, K., Willingham, H. & Cucinotta, F. A. Stability of chromosome aberrations in the blood lymphocytes of astronauts measured after space flight by FISH chromosome painting. Radiat. Res. 164, 474-480 (2005).
52. Durante, M. et al. Chromosome aberration dosimetry in cosmonauts after single or multiple space flights. Cytogenet. Genome Res. 103, 40-46 (2003).
53. Fry, R. J. M. & Storer, J. B. External radiation carcinogenesis. Adv Radiat. Biol. 13, 31-91 (1987).
54. Alpen, E. L., Powers-Risius, P., Curtis, S. B. & DeGuzman, R. Tumorigenic potential of high-Z, high-LET charged-particle radiations. Radiat. Res. 136, 382-391 (1993).
55. Dicello, J. F. et al. In vivo mammary tumorigenesis in the Sprague-Dawley rat and microdosimetric correlates. Phys. Med. Biol. 49, 3817-3830 (2004).
56. Ando, K. et al. Tumor induction in mice locally irradiated with carbon ions: a retrospective analysis. J. Radiat. Res. 46, 185-190 (2005).
57. Kadhim, M. A. et al. Transmission of chromosomal instability after plutonium ? particle irradiation. Nature 355, 738-740 (1992).
58. Sabatier, L., Dutrillaux, B. & Martin, M. Chromosomal instability. Nature 357, 548 (1992).
59. Sieber, O. M., Heinimann, K. & Tomlison, I. P. Genomic instability - the engine of tumorigenesis? Nature Rev. Cancer 3, 701-708 (2003).
60. Huang, L., Snyder, A. R. & Morgan, W. F. Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene 22, 5848-5854 (2003).
61. Kadhim, M. A., Hill, M. A. & Moore, S. R. Genomic instability and the role of radiation quality. Radiat. Prot. Dosim. 122, 221-227 (2006).
62. Park, C. C. et al. Ionizing radiation induces heritable disruption of epithelial cell interactions. Proc. Natl Acad. Sci. USA 100, 10728-10733 (2003).
63. Kusunoki, T. & Hayashi, T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int. J. Radiat. Biol. 31, 1-14 (2007).
64. Rola, R. et al. High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat. Res. 164, 556-560 (2005).
65. Mothersill, C. & Seymour, B. Radiation-induced bystander effects--implications for cancer. Nature Rev. Cancer. 4, 158-164 (2004).
66. Sokolov, M. V., Dickey, J. S., Bonner, W. M. & Sedelnikova, O. A. ?-H2AX in bystander cells: not just a radiation-triggered event, a cellular response to stress mediated by intercellular communication. Cell Cycle 6, 2210-2222 (2007).
67. Barcellos-Hoff, M. H, Park, C. & Wright, E. G. Radiation and the microenvironment-tumorigenesis and therapy. Nature Rev. Cancer 5, 867-75 (2005).
68. Preston, D. L. et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 168, 1-64 (2007).
69. Cardis, E. et al. The 15-country collaborative study of cancer risks among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat. Res. 167, 396-416 (2007).
70. Sato, M. et al. Multiple oncogenic changes (K-RASv12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 66, 2116-2128 (2006).
71. National Council on Radiation Protection and Measurements. Extrapolation of radiation-induced cancer risks from nonhuman experimental systems to humans. NCRP Report No. 150 (National Council on Radiation Protection and Measurements, Bethesda, 2006).
72. Berie, B. & Moses, H. L. Tumour microenvironment: TGF?: the molecular Jekyll and Hyde of cancer. Nature Rev. Cancer 6, 506-520 (2006).
73. Kirshner, J. et al. Inhibition of transforming growth factor-?1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res. 66, 10861-10869 (2006).
74. Andarawewa, K. L. et al. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor β-induced epithelial to mesenchymal transition. Cancer Res. 67, 8662-8670 (2007).
75. Weiss, J. F. & Landauer, M. R. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 189, 1-20 (2003).
76. Sasse, A. D., Clark, L. G., Sasse, E. C. & Clark, O. A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a metaanalysis. Int. J. Radiat. Oncol. Biol. Phys. 64, 784-791 (2006).
77. Boccia, R. Improved tolerability of amifostine with rapid infusion and optimal patient preparation. Semin. Oncol. 29, S9-S13 (2002).
78. Halliwell, B. The antioxidant paradox. Lancet 375, 1179-1180 (2000).
79. Bingham, S. & Riboli, E. Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nature Rev. Cancer 4, 206-215 (2004).
80. Sauvaget, C., Kasagi, F. & Waldren, C. A. Dietary factors and cancer mortality among atomic-bomb survivors. Mutat. Res. 551, 145-152 (2004).
81. Weiss, J. F. & Landauer, M. N. Radioprotection by antioxidants. Ann. NY Acad. Sci. 899, 44-60 (2000).
82. Smith, S. M. et al. The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. J. Nutr. 135, 437-443 (2005).
83. Waldren, C. A., Vannais, D. B. & Ueno, A. M. A role for long-lived radicals (LLR) in radiation-induced mutation and persistent chromosomal instability: counteraction by ascorbate and RibCys but not DMSO. Mutat. Res. 551, 255-265 (2004).
84. Burns, F. J. et al. Induction and prevention of carcinogenesis in rat skin exposed to space radiation. Radiat. Environ. Biophys. 46, 195-199 (2007).
85. Guan, J. et al. Effects of dietary supplements on the space radiation-induced reduction in total antioxidant status in CBA mice. Radiat. Res. 165, 373-378 (2006).
86. Kennedy, A. R., Guan, J. & Ware, J. H. Countermeasures against space radiation induced oxidative stress in mice. Radiat. Environ. Biophys. 46, 201-203 (2007).
87. Rabin, B. M., Joseph, J. A. & Shukitt-Hale, B. Effects of age and diet on the heavy particle-induced disruption of operant responding produced by a ground-based model for exposure to cosmic rays. Brain Res. 1036, 122-129 (2005).
88. Bjelakovic, G. et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857 (2007).
89. Kovalchuk, O. et al. Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat. Res. 548, 75-84 (2004).
90. Kyoizumi, S. et al. Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study of erythrocyte glycophorin gene mutations of Atomic bomb survivors. Cancer Res. 65, 5462-5469 (2005).
91. Ponder, A. J. Cancer Genetics. Nature 411, 336-341 (2001).
92. Thompson, D. et al. Cancer risks and mortality in heterozygous ATM mutations carriers. J. Natl Cancer Inst. 97, 813-822 (2005).
93. Smilenov, L. B., Brenner, D. J. & Hall, E. J. Modest increased sensitivity to radiation oncogenesis in ATM heterozygous versus wild-type mammalian cells. Cancer Res. 61, 5710-5713 (2001).
94. Worgul, B. V. et al. Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc. Natl Acad. Sci. USA. 99, 9836-9839 (2002).
95. Kleinman, N. J. et al. Mrad9 and ATM haploinsufficiency enhance spontaneous and X-ray-induced cataractogenesis in mice. Radiat. Res. 168, 567-573 (2007).
96. Baeyens, A. et al. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int. J. Radiat. Biol. 80, 745-756 (2004).
97. Kato, T. A. et al. A defect in DNA double strand break processing in cells from unaffected parents of retinoblastoma patients and other apparently normal humans. DNA Repair 8, 818-829 (2007).
98. Flint-Richter, P. & Sadetzki, S. Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol. 8, 403-410 (2007).
99. Hall, E. J. Cancer caused by x-rays - a random event? Lancet Oncol. 8, 369-370 (2007).
100. Hall, E. J. et al. The relative biological effectiveness of densely ionizing heavy-ion radiation for inducing ocular cataracts in wild type versus mice heterozygous for the ATM gene. Radiat. Environ. Biophys. 45, 99-104 (2006).
101. Wilson, J. W. et al. Issues in protection from galactic cosmic rays. Radiat. Environ. Biophys. 34, 217-222 (1995).
102. Simonsen, L. C., Wilson, J. W., Kim, M. H. & Cucinotta, F. A. Radiation exposure for human Mars exploration. Health Phys. 79, 515-525 (2000).
103. Agostinelli, S. et al. Geant4: a simulation toolkit. Nucl. Instr. Meth. A506, 250-303 (2003).
104. Miller, J. et al. Benchmark studies of the effectiveness of structural and internal materials as radiation shielding for the International Space Station. Radiat. Res. 159, 381-390 (2003).
105. Durante, M. et al. Cytogenetic effects of high-energy iron ions: dependence on shielding thickness and material. Radiat. Res. 164, 571-576 (2005).
106. Lobascio, C. et al. Accelerator-based tests of radiation shielding properties of materials used in human space infrastructures. Health Phys. 94, 242-245 (2008).
107. Vana, N. et al. Novel shielding materials for space and air travel. Radiat. Prot. Dosim. 120, 405-409 (2006).
108. Parker, E. N. Shielding space travelers. Sci. Am. 294, 40-47 (2006).
109. Spillantini, P. et al. Shielding from cosmic radiation for interplanetary missions: active and passive methods. Radiat. Meas. 42, 14-23 (2007).
110. Kiefer, J. & Pross, H. D. Space radiation effects and microgravity. Mutat. Res. 430, 299-305 (1999).
111. Durante, M. & Kronenberg, A. Ground-based research with heavy ions for space radiation protection. Adv. Space Res. 35, 180-184 (2005).
112. Schimmerling, W., Cucinotta, F. A. & Wilson, J. W. Radiation risk and human space exploration. Adv. Space Res. 31, 27-34 (2003).
113. Durante, M. et al. Preparatory study of a ground-based space radiobiology program in Europe. Adv. Space Res. 32, 1082-1086 (2007).
114. Amaldi, U. & Kraft, G. Radiotherapy with beams of carbon ions. Rep. Prog. Phys. 68, 1861-1882 (2005).
115. Schulz-Ertner, D. & Tsujii, H. Particle radiation therapy using proton and heavier ion beams. J. Clin. Oncol. 25, 953-964 (2007).
116. Hall, E. J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 65, 1-7 (2006).
117. Allan, J. M. & Travis, L. B. Mechanisms of therapy-related carcinogenesis. Nature Rev. Cancer 5, 943-955 (2005).
118. Durante, M. Heavy ion radiobiology for hadrontherapy and space radiation protection. Radiother. Oncol. 73, S158-S160 (2004).